The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shatova O.P.

Pirogov Russian National Research Medical University

Zabolotneva A.A.

Pirogov Russian National Research Medical University

Mikin I.E.

All-Russian Non-Governmental Organization of Small and Medium Business «Opora Russia»

Bril D.V.

International Association of Research, Environmental, Medical and Educational Organizations, Producers and Consumers of Goods and Services in the Field of Public Health and Active Longevity «Quality of Life»

Shestopalov A.V.

Pirogov Russian National Research Medical University;
Molecular Health Center LLC

Roumiantsev S.A.

Pirogov Russian National Research Medical University;
Molecular Health Center LLC

The role of tryptophan metabolites in metabolism and pathogenesis of obesity

Authors:

Shatova O.P., Zabolotneva A.A., Mikin I.E., Bril D.V., Shestopalov A.V., Roumiantsev S.A.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2022;25(10): 97‑103

DOI: 10.17116/profmed20222510197

Read: 17307 times

Contact the author
Table of contents

THE ROLE OF TRYPTOPHAN METABOLITES IN METABOLISM AND PATHOGENESIS OF OBESITY
THE ROLE OF TRYPTOPHAN METABOLITES IN METABOLISM AND PATHOGENESIS OF OBESITY

To cite this article:

Shatova OP, Zabolotneva AA, Mikin IE, Bril DV, Shestopalov AV, Roumiantsev SA. The role of tryptophan metabolites in metabolism and pathogenesis of obesity. Russian Journal of Preventive Medicine. 2022;25(10):97‑103. (In Russ.)
https://doi.org/10.17116/profmed20222510197

Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Hype­rtensive diso­rders of pregnancy as a risk factor for chro­nic non-communicable diseases. Russian Journal of Preventive Medi­cine. 2025;(6):114-119
Analysis of the different approaches effe­ctiveness to the treatment of patients with obesity. Russian Journal of Preventive Medi­cine. 2025;(6):120-125
Sarcopenia index for dete­cting of the decreased muscle stre­ngth and mass in patients with the non-alcoholic fatty liver disease. Russian Journal of Preventive Medi­cine. 2025;(7):68-74
Features of comprehensive treatment in a patient with complicated type 2 diabetes mellitus: A clinical case. Piro­gov Russian Journal of Surgery. 2025;(6):128-132
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Drinking mine­ral water for progressive resi­stance to insu­lin. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(2):24-30
Cere­brovascular disease in clinical practice. Reso­lution of the Expert Council of the Russian Scientific Medi­cal Society of Therapists. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):105-111
Late complications and quality of life after multivisceral surgeries with pancreatoduodenectomy. Piro­gov Russian Journal of Surgery. 2025;(7):36-45
Influence of carriage of papi­llomavirus infe­ction on the course of exte­rnal geni­tal endo­metriosis in patients with intraepithelial lesion of the cervix. Russian Journal of Human Reproduction. 2025;(3):77-83
Painful diabetic poly­neuropathy in patients with cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):64-72
Abstract:

For humans, the amino acid tryptophan is essential and highly sought after. In addition to participating in protein synthesis, tryptophan undergoes conversion to tryptamine and indole metabolites by enzymes of the gut microbiota. In human cells, tryptophan is utilized through the kynurenine pathway and is converted into the biogenic amine serotonin. Indole-3-acetate and indole-3-propionate are of great importance for the regulation of lipid synthesis. These metabolites inhibit lipogenesis and prevent the development of non-alcoholic fatty liver disease, which is often a concomitant condition in obesity. Indole and serotonin have anorexigenic effects. Indole-3-lactate has a pronounced neurotropic effect. It was found that obesity is associated with a characteristic phenotype of intestinal dysbiosis. Taxonomic and metabolic changes in the gut microbiota result in impaired tryptophan synthesis and altered levels of its metabolites in the body. Obese patients are characterized by decreased plasma tryptophan levels. Proper dietary adjustments, pro-, pre-, symbiotics, and tryptophan supplements can contribute to obesity prevention and treatment.

Keywords:

tryptophan
indoles
serotonin
kynurenine
microbiota
obesity
diabetes

Authors:

Shatova O.P.

Pirogov Russian National Research Medical University

Zabolotneva A.A.

Pirogov Russian National Research Medical University

Mikin I.E.

All-Russian Non-Governmental Organization of Small and Medium Business «Opora Russia»

Bril D.V.

International Association of Research, Environmental, Medical and Educational Organizations, Producers and Consumers of Goods and Services in the Field of Public Health and Active Longevity «Quality of Life»

Shestopalov A.V.

Pirogov Russian National Research Medical University;
Molecular Health Center LLC

Roumiantsev S.A.

Pirogov Russian National Research Medical University;
Molecular Health Center LLC

Received:

24.01.2022

Accepted:

11.07.2022

Close metadata

References:

  1. Bik EM. You Lose Some, You Win Some: Weight Loss Induces Microbiota and Metabolite Shifts. EBioMedicine. 2015;2(8):806-807.  https://doi.org/10.1016/j.ebiom.2015.07.037
  2. Silveira EA, da Silva Filho RR, Spexoto MCB, et al. The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications. International Journal of Molecular Sciences. 2021;22(9):4339. https://doi.org/10.3390/ijms22094339
  3. Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C. Visceral obesity and incident cancer and cardiovascular disease: An integrative review of the epidemiological evidence. Obesity Reviews. 2021;22(1):e13088. https://doi.org/10.1111/obr.13088
  4. Barazzoni R, Bischoff SC, Boirie Y, et al. Sarcopenic obesity: Time to meet the challenge. Clinical Nutrition. 2018;37(6 Pt A):1787-1793. https://doi.org/10.1016/j.clnu.2018.04.018
  5. Zhang C, Yin A, Li H, et al. Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children. EBioMedicine. 2015;2(8):968-984.  https://doi.org/10.1016/j.ebiom.2015.07.007
  6. Butler MG, Miller JL, Forster JL. Prader-Willi Syndrome — Clinical Genetics, Diagnosis and Treatment Approaches: An Update. Current Pediatric Reviews. 2019;15(4):207-244.  https://doi.org/10.2174/1573396315666190716120925
  7. Agus A, Planchais J, Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host and Microbe. 2018;23(6):716-724.  https://doi.org/10.1016/j.chom.2018.05.003
  8. Shestopalov AV, Shatova OP, Zabolotneva A.A., Gaponov AM, Moskaleva NE, Appolonova SA, Makarov VV, Yudin SM, Rumantsev AG, Roumiantsev SA. Features of conjugation of intestinal and serum pools of indoles in obesity. Voprosy biologicheskoy, medicinskoy i farmacivticheskoy himii. 2021;24(10):3-12. (In Russ.). https://doi.org/10.29296/25877313-2021-10-01
  9. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(3):979-84.  https://doi.org/10.1073/pnas.0605374104
  10. Tap J, Mondot S, Levenez F, et al. Towards the human intestinal microbiota phylogenetic core. Environmental Microbiology. 2009;11(10):2574-2584. https://doi.org/10.1111/j.1462-2920.2009.01982.x
  11. Tamana SK, Tun HM, Konya T, et al. Bacteroides-dominant gut microbiome of late infancy is associated with enhanced neurodevelopment. Gut Microbes. 2021;13(1):1-17.  https://doi.org/10.1080/19490976.2021.1930875
  12. Kelsey CM, Prescott S, McCulloch JA, et al. Gut microbiota composition is associated with newborn functional brain connectivity and behavioral temperament. Brain, Behavior, and Immunity. 2021;91:472-486.  https://doi.org/10.1016/j.bbi.2020.11.003
  13. Weitkunat K, Schumann S, Nickel D, et al. Odd-chain fatty acids as a biomarker for dietary fiber intake: a novel pathway for endogenous production from propionate. American Journal of Clinical Nutrition. 2017;105(6):1544-1551. https://doi.org/10.3945/ajcn.117.152702
  14. Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clinical Microbiology Reviews. 2022;35(1):e0033820. https://doi.org/10.1128/CMR.00338-20
  15. Shestopalov AV, Shatova OP, Karbishev MS, Gaponov AM, Moskaleva NE, Appolonova SA, Tutelyan AV, Makarov VV, Yudin SM, Roumiantsev SA. The «kynurenine switch» and obesity. Byulleten’ sibirskoj mediciny. 2021; 20(4):103-111. (In Russ.). https://doi.org/10.20538/1682-0363-2021-4-103-111
  16. Conroy KP, Davidson IM, Warnock M. Pathogenic obesity and nutraceuticals. Proceedings of the Nutrition Society. 2011;70(4):426-438.  https://doi.org/10.1017/S0029665111001662
  17. Ji Y, Gao Y, Chen H, Yin Y, Zhang W. Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress. Nutrients. 2019;11(9):2062. https://doi.org/10.3390/nu11092062
  18. Knudsen C, Neyrinck AM, Lanthier N, Delzenne NM. Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions? Current Opinion in Clinical Nutrition and Metabolic Care. 2019;22(5):393-400.  https://doi.org/10.1097/MCO.0000000000000584
  19. Dong F, Hao F, Murray IA, et al. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes. 2020;12(1):1-24.  https://doi.org/10.1080/19490976.2020.1788899
  20. Zelante T, Iannitti RG, Cunha C, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39(2):372-385.  https://doi.org/10.1016/j.immuni.2013.08.003
  21. Barthelemy A, Sencio V, Soulard D, et al. Interleukin-22 Immunotherapy during Severe Influenza Enhances Lung Tissue Integrity and Reduces Secondary Bacterial Systemic Invasion. Infection and Immunity. 2018;86(7): e00706-00717. https://doi.org/10.1128/IAI.00706-17
  22. de Mello VD, Paananen J, Lindström J, et al. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Scientific Reports. 2017;7:46337. https://doi.org/10.1038/srep46337
  23. Ehrlich AM, Pacheco AR, Henrick BM, et al. Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiology. 2020;20(1):357.  https://doi.org/10.1186/s12866-020-02023-y
  24. van Galen KA, Ter Horst KW, Booij J, la Fleur SE, Serlie MJ. The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies. Metabolism. 2018;85:325-339.  https://doi.org/10.1016/j.metabol.2017.09.007
  25. Maffei ME. 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. International Journal of Molecular Sciences. 2020;22(1):181.  https://doi.org/10.3390/ijms22010181
  26. van Galen KA, Ter Horst KW, Serlie MJ. Serotonin, food intake, and obesity. Obesity Reviews. 2021;22(7):e13210. https://doi.org/10.1111/obr.13210
  27. McCuen-Wurst C, Ruggieri M, Allison KC. Disordered eating and obesity: associations between binge-eating disorder, night-eating syndrome, and weight-related comorbidities. Annals of the New York Academy of Sciences. 2018;1411(1):96-105.  https://doi.org/10.1111/nyas.13467
  28. Blum K, Gold MS, Llanos-Gomez L, et al. Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction? International Journal of Environmental Research and Public Health. 2021;18(18):9774. https://doi.org/10.3390/ijerph18189774
  29. Gutiérrez-Vázquez C, Quintana FJ. Regulation of the Immune Response by the Aryl Hydrocarbon Receptor. Immunity. 2018;48(1):19-33.  https://doi.org/10.1016/j.immuni.2017.12.012
  30. Vyhlídalová B, Krasulová K, Pečinková P, et al. Gut Microbial Catabolites of Tryptophan are Ligands and Agonists of the Aryl Hydrocarbon Receptor: A Detailed Characterization. International Journal of Molecular Sciences. 2020;21(7):2614. https://doi.org/10.3390/ijms21072614
  31. Kumar P, Lee JH, Lee J. Diverse roles of microbial indole compounds in eukaryotic systems. Biological Reviews of the Cambridge Philosophical Society. 2021;96:2522-2545. https://doi.org/10.1111/brv.12765
  32. Kurata K, Kawahara H, Nishimura K, et al. Skatole regulates intestinal epithelial cellular functions through activating aryl hydrocarbon receptors and p38. Biochemical and Biophysical Research Communications. 2019;510(4):649-655.  https://doi.org/10.1016/j.bbrc.2019.01.122
  33. Wang D, Li D, Zhang Y, et al. Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage. Acta Pharmaceutica Sinica. B. 2021;11(3):763-780.  https://doi.org/10.1016/j.apsb.2020.07.017
  34. Szelest M, Walczak K, Plech T. A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological Processes. International Journal of Molecular Sciences. 2021;22(3):1104. https://doi.org/10.3390/ijms22031104
  35. Esser C, Rannug A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacological Reviews. 2015;67(2): 259-279.  https://doi.org/10.1124/pr.114.009001
  36. Bock KW. Human and rodent aryl hydrocarbon receptor (AHR): from mediator of dioxin toxicity to physiologic AHR functions and therapeutic options. Biological Chemistry. 2017;398(4):455-464.  https://doi.org/10.1515/hsz-2016-0303
  37. Izawa T, Arakaki R, Mori H, et al.The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis. Journal of Immunology. 2016;197(12):4639-4650. https://doi.org/10.4049/jimmunol.1600822
  38. Venkatesh M, Mukherjee S, Wang H, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 2014;41(2):296-310.  https://doi.org/10.1016/j.immuni.2014.06.014
  39. Rogers RS, Parker A, Vainer PD, et al. The Interface between Cell Signaling Pathways and Pregnane X Receptor. Cells. 2021;10(11):3262. https://doi.org/10.3390/cells10113262
  40. Konopelski P, Mogilnicka I. Biological Effects of Indole-3-Propionic Acid, a Gut Microbiota-Derived Metabolite, and Its Precursor Tryptophan in Mammals’ Health and Disease. International Journal of Molecular Sciences. 2022;2(3):1222. https://doi.org/10.3390/ijms23031222
  41. Zhang B, Jiang M, Zhao J, Song Y, Du W, Shi J. The Mechanism Underlying the Influence of Indole-3-Propionic Acid: A Relevance to Metabolic Disorders. Frontiers in Endocrinology. 2022;13:841703. https://doi.org/10.3389/fendo.2022.841703
  42. Agudelo LZ, Ferreira DMS, Cervenka I, et al. Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation. Cell Metabolism. 2018;27(2):378-392.e5.  https://doi.org/10.1016/j.cmet.2018.01.004
  43. Voigt JP, Fink H. Serotonin controlling feeding and satiety. Behavioural Brain Research. 2015;277:14-31.  https://doi.org/10.1016/j.bbr.2014.08.065
  44. Halford JC, Harrold JA, Boyland EJ, Lawton CL, Blundell JE. Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs. 2007;67(1):27-55.  https://doi.org/10.2165/00003495-200767010-00004
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.